CymitQuimica logo

CAS 1391918-17-4

:

Raltegravir EP impurity C

Description:
Raltegravir EP impurity C, with the CAS number 1391918-17-4, is a chemical compound associated with the antiretroviral drug raltegravir, which is used in the treatment of HIV. As an impurity, it is typically a byproduct of the synthesis process and may not be present in significant quantities in the final pharmaceutical product. The characteristics of this impurity can include its molecular structure, which is related to the parent compound, and its physical properties such as solubility, melting point, and stability under various conditions. Impurities like Raltegravir EP impurity C are important to monitor in pharmaceutical formulations to ensure safety, efficacy, and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities. Understanding the characteristics of impurities is crucial for quality control in drug manufacturing, as they can affect the overall therapeutic profile and safety of the medication.
Formula:C20H23FN6O6
Synonyms:
  • Raltegravir USP Impurity E
  • Acetic acid, 2-[[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]amino]-2-oxo-, 2-acetylhydrazide
  • Raltegravir Impurity 3(Raltegravir EP Impurity C)
  • Raltegravir Oxalylacetohydrazide Analog
  • Raltegravir EP impurity C
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.